Efficacy analysis and prognostic factors of first-line chemotherapy combined with immunotherapy in extensive-stage small cell lung cancer: a real-world study
Crossref DOI link: https://doi.org/10.1038/s41598-025-98018-8
Published Online: 2025-04-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Jian-Xi
Sun, Yun-Chuan
Xiao, Li
Lu, Hong-Ling
Yin, Xiao-Ming
Fan, Kui
Zhou, Ying-Nan
Text and Data Mining valid from 2025-04-16
Version of Record valid from 2025-04-16
Article History
Received: 5 October 2024
Accepted: 8 April 2025
First Online: 16 April 2025
Declarations
:
: The authors declare no competing interests.